Cell Stem Cell Review Time
Cell Stem Cell's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.
Research Scientist, Neuroscience & Cell Biology
Author context
Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.
What to do next
Already submitted to Cell Stem Cell? Use this page to interpret the status and choose the next step.
The useful next step is understanding what the status usually means at Cell Stem Cell, how long the wait normally runs, and when a follow-up is actually reasonable.
Cell Stem Cell review timeline: what the data shows
Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.
What shapes the timeline
- Desk decisions are fast. Scope problems surface within days.
- Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
- Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.
What to do while waiting
- Track status in the submission portal — status changes signal active review.
- Wait at least the journal's stated median before sending a status inquiry.
- Prepare revision materials in parallel if you expect a revise-and-resubmit decision.
Quick answer: Cell Stem Cell review time looks extremely fast on the first number and much more normal on the full path. The journal's ScienceDirect insights page currently reports 4 days to first decision, 33 days to decision after review, and 170 days from submission to acceptance. That tells you the same story many authors eventually learn the hard way: Cell Stem Cell is very fast at deciding whether the paper belongs in the conversation, and much slower once the manuscript survives and has to prove it deserves the journal's mechanism-and-function standard.
Cell Stem Cell metrics at a glance
Metric | Current value | What it means for authors |
|---|---|---|
Submission to first decision | 4 days | Cell Press triage is very fast |
Submission to decision after review | 33 days | Reviewed files can still move on a disciplined clock |
Submission to acceptance | 170 days | The real path is much longer than the desk number |
Impact Factor (JCR 2024) | 20.4 | Cell Stem Cell remains the specialized flagship for stem cell biology |
CiteScore (2024) | 32.9 | Citation strength remains very high inside the field |
APC (OA option) | $10,400 | Open access is optional and expensive |
Main fit test | Functional proof plus mechanistic consequence | Descriptive stem cell papers struggle |
Editorial model | Cell Press professional editors | Identity and completeness get judged quickly |
The useful reading is not "this journal is fast." The useful reading is "this journal is fast at saying no, and selective about what earns a longer process."
What the official numbers do and do not tell you
ScienceDirect gives unusually concrete timing information for Cell Stem Cell.
It tells you:
- editors usually know quickly whether a submission deserves more time
- reviewed papers can move efficiently once they are in the system
- the full acceptance path still includes a meaningful revision burden
It does not tell you:
- how many papers fail because the story is still descriptive rather than functional
- how much of the 170-day number comes from major mechanistic revisions
- how often the real problem is not speed but submitting a beautiful stem cell paper that is not yet a Cell Stem Cell paper
That difference matters because Cell Stem Cell is not just choosing the best-looking data. It is screening for function-first stem cell biology.
A practical timeline authors can actually plan around
Stage | Practical expectation | What is happening |
|---|---|---|
Editorial intake | A few days | Editors decide whether the package already looks Cell Stem Cell-ready |
Desk decision | Often close to the 4-day official benchmark | Descriptive or incomplete stories get filtered very early |
Reviewer recruitment | Several days to about 1 week | The journal wants reviewers who can judge both mechanism and function |
Decision after review | Often close to the 33-day official benchmark | Reviewed papers move with a fairly disciplined process |
Revision cycle | Several weeks to months | Functional validation and scope calibration are common demands |
Acceptance | Around the 170-day official benchmark | The real author clock includes revision and editorial standards |
This is why the journal can feel brutal at the front and still not be a truly short full-cycle venue.
Why Cell Stem Cell often feels fast at the desk
Cell Stem Cell has a very clear editorial identity. Editors often reject quickly when a paper is:
- strong in single-cell profiling but weaker in function
- elegant in organoid or iPSC characterization but still thin on biological consequence
- interesting inside one system but not broad enough for the stem cell field
- mechanistically suggestive rather than mechanistically demonstrated
- better suited to Developmental Cell, Cell Reports, Stem Cell Reports, or a tissue-specific journal
That speed is not accidental. It reflects a journal that knows the difference between stem cell data and stem cell argument.
What usually slows Cell Stem Cell down
The slower papers are usually the ones that the journal takes seriously and then tests hard.
The common causes are:
- reviewer pressure for stronger functional validation
- disagreements about whether the finding changes broader stem cell thinking
- requests for cleaner in vivo support or orthogonal evidence
- revision rounds where descriptive additions do not solve mechanistic doubts
- manuscripts that are close enough to review but not yet complete enough to finish cleanly
When Cell Stem Cell feels slow, the reason is often that the paper is being asked to become more truly Cell Stem Cell-like.
Cell Stem Cell impact-factor trend and what it means for review time
Year | Impact Factor |
|---|---|
2017 | 23.3 |
2018 | 21.5 |
2019 | 20.9 |
2020 | 24.6 |
2021 | 25.3 |
2022 | 23.9 |
2023 | 19.8 |
2024 | 20.4 |
Cell Stem Cell is up from 19.8 in 2023 to 20.4 in 2024, even though it remains below the 2020 to 2022 spike.
For review time, the main implication is that the journal still has enough demand and prestige to keep its fast triage behavior. It does not need to soften the first screen.
How Cell Stem Cell compares with nearby journals on timing
Journal | Timing signal | Editorial posture |
|---|---|---|
Cell Stem Cell | Very fast triage, moderate full path | Functional stem cell biology with high selectivity |
Developmental Cell | Slower and more development-focused | Better if developmental mechanism is the center |
Nature Cell Biology | Comparable elite scrutiny with broader cell-biology scope | Better when stem cells are not the only real audience |
Cell Reports | More accessible and less function-purist | Better for strong but less complete stories |
Stem Cell Reports | Cleaner fit for solid field papers without the same flagship bar | Good when completeness is strong but consequence is narrower |
This matters because many authors experiencing "timing problems" at Cell Stem Cell are really experiencing a target problem. The paper can be good and still be one journal too high.
Readiness check
While you wait on Cell Stem Cell, scan your next manuscript.
The scan takes 60 seconds. Use the result to decide whether to revise before the decision comes back.
What review-time data hides
Even good journal insights data hide several things:
- the 4-day number is mostly a triage number
- the reviewed-paper path still depends on functional proof
- the journal is screening for biological consequence, not only technical ambition
- timing alone cannot rescue a manuscript that is still descriptive
So the numbers help, but the real determinant is whether the evidence package already carries the editorial argument.
In our pre-submission review work with Cell Stem Cell manuscripts
In our pre-submission review work, the biggest timing mistake is assuming that a paper with strong single-cell atlases, organoids, or lineage description should go to Cell Stem Cell first because the desk answer comes back quickly.
The papers that move best here usually have:
- functional proof visible in the early figures
- a mechanistic claim that does not depend on reviewer generosity
- significance that extends beyond one protocol or tissue compartment
- enough completeness that revision is about sharpening, not rescuing
Those traits make the journal's speed work for the manuscript rather than against it.
Submit if / Think twice if
Submit if the paper already demonstrates function, mechanism, and broader stem cell consequence in a way that feels complete before submission.
Think twice if the manuscript is still mainly descriptive, still leaning on inferred biology, or still one obvious functional experiment short. In those cases, the review-time question is usually not the real bottleneck.
What should drive the submission decision instead
For Cell Stem Cell, timing matters less than functional completeness. The better question is whether the current package already behaves like a function-first stem cell paper.
That is why the better next reads are:
- Cell Stem Cell journal profile
- Cell Stem Cell submission guide
- Cell Stem Cell submission process
- Is Cell Stem Cell a good journal?
A Cell Stem Cell readiness check is usually more useful than focusing on the 4-day triage number.
Practical verdict
Cell Stem Cell review time is fast where the journal is confident and slower where the science has to earn its place. The front end is extremely quick. The full path is not. If the manuscript truly has function and mechanism already in hand, the process can be efficient. If not, the journal usually tells you quickly, and that is the most useful part of the clock.
Frequently asked questions
Cell Stem Cell's ScienceDirect insights page currently reports 4 days from submission to first decision. That number reflects very fast Cell Press triage and should not be confused with the full reviewed-paper path.
Cell Stem Cell currently reports 33 days from submission to decision after review on its ScienceDirect insights page. That suggests reviewed manuscripts can move in a disciplined way once they clear triage.
Cell Stem Cell currently reports 170 days from submission to acceptance. That is the better planning number for authors because it captures the real revision burden.
Functional proof matters more than speed. If the paper does not already demonstrate what the cells do and why, the main issue is usually readiness and fit, not review tempo.
Sources
- 1. Cell Stem Cell journal insights, ScienceDirect.
- 2. Cell Stem Cell guide for authors, Cell Press.
- 3. Cell Stem Cell impact history, BioxBio.
- 4. Cell Stem Cell presubmission inquiry, Cell Press.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: whether the package is ready, what drives desk rejection, how journals compare, and what the submission requirements look like across journals.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Best next step
Use this page to interpret the status and choose the next sensible move.
For Cell Stem Cell, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.
Guidance first. Use the scan for the next manuscript.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Cell Stem Cell Submission Process: What Happens After You Upload
- How to Avoid Desk Rejection at Cell Stem Cell
- Cell Stem Cell Impact Factor 2026: 20.4, Q1, Rank 1/32
- Is Cell Stem Cell a Good Journal? Impact, Scope, and Fit
- Cell Stem Cell Cover Letter: What Editors Actually Need to See
- Cell Stem Cell Formatting Requirements: The Cell Press Package Guide
Supporting reads
Use this page to interpret the status and choose the next sensible move.
Guidance first. Use the scan for the next manuscript.